Epilepsy Diagnosis and Treatment Market Share, Growth, Drivers, Emerging Technologies, and Forecast Research Report 2030
Epilepsy Diagnosis and Treatment Market Highlights
Increasing prevalence of epilepsy, rising number of
traumatic brain injury cases, growing geriatric population, and rising
healthcare expenditures are the major drivers for the global Epilepsy
Diagnosis and Treatment Market However, high cost of therapeutic surgeries,
low per capita healthcare expenditure, and lack of awareness for the disease in
emerging economies are estimated to restrain the market growth during the
projected period.
The epilepsy diagnosis and treatment market are expected to
reach USD 9130.74 Million by 2030 at 14.90% CAGR during the forecast period
2022-2030.
Segmentation
The global epilepsy diagnosis and treatment market is
segmented on the basis of type, diagnosis, treatment, and end-user.
·
On the basis of type, the market is
segmented into idiopathic, cryptogenic, symptomatic, and others.
·
On the basis of diagnosis, the market is
segmented into neurological exam, blood test, imaging, and medical
diagnosis kit. The imaging segment is sub-segmented into
electroencephalogram, computerized tomography, magnetic resonance imaging,
positron emission tomography, and others.
·
On the basis of treatment, the market is
segmented into medication, surgery, brain stimulation, and others. The
medication segment is sub-segmented into acetazolamide, carbamazepine,
clobazam, and others. The surgery segment is sub-segmented into
hemispherectomy, corpus callosotomy, resection surgery, and others. The brain
stimulation segment is sub-segmented into deep brain stimulation, responsive
neurostimulation, and others.
·
On the basis of end user, the market is
segmented into hospitals & clinics, diagnostic centers, and others.
Key Players
The key for the global Epilepsy
Diagnosis and Treatment Market Players are
Pfizer, Inc. (U.S.), Johnson & Johnson Services, Inc.
(U.S.), UCB Pharma Ltd. (U.K), Abbott (U.S.), GlaxoSmithKline plc (U.K),
Novartis International AG (Switzerland), Sanofi S.A. (France), Shire (Republic
of Ireland), Medtronic (U.S.), NeuroWave Systems Inc. (U.S.), Natus Medical
Incorporated. (U.S.), Siemens Ltd. (Germany),
Regional Analysis
The Americas dominate the global epilepsy diagnosis and
treatment market, which can be attributed to the presence of a well-developed
healthcare sector and huge patient population within the region. Moreover,
increasing number of head trauma cases boosts the American market. Europe holds
the second largest market share owing to the availability of funds for
research, presence of a well-developed healthcare sector, and government
support. Followed by Europe, the Asia Pacific region is projected to be the fastest
growing region for the global epilepsy diagnosis and treatment market. Presence
of developing healthcare sector, along with emerging economies of the Asia
Pacific region boosts the market growth. The Middle East & Africa has the
least share in the global epilepsy diagnosis and treatment market, owing to the
low per capita healthcare expenditures, lack of awareness for the disease, and
stringent government policies, especially in the African region. On the other
hand, the Middle East region within the Middle East & Africa is estimated
to be fastest growing region due to growing healthcare expenditures and
presence of the developed economies, such as Kuwait, Qatar, Dubai, and others.
Related Report-
·
Auto-Injectors
Market Research Report- Forecast to 2027
·
Anemia
Drugs Market Research Report- Global Forecast to 2027 | MRFR
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients. Our market research studies by Components,
Application, Logistics and market players for global, regional, and country
level market segments, enable our clients to see more, know more, and do more,
which help to answer all their most important questions.
Contact:
Market
Research Future®
99
Hudson Street,5Th Floor
New
York, New York 10013
United
States of America
Comments
Post a Comment